BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30120594)

  • 1. Association of HER2 gene amplification and tumor progression in early gastric cancer.
    Kanayama K; Imai H; Usugi E; Shiraishi T; Hirokawa YS; Watanabe M
    Virchows Arch; 2018 Nov; 473(5):559-565. PubMed ID: 30120594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel gene-protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity.
    Nishida Y; Kuwata T; Nitta H; Dennis E; Aizawa M; Kinoshita T; Ohtsu A; Ochiai A
    Gastric Cancer; 2015 Jul; 18(3):458-66. PubMed ID: 24917219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages.
    Cho J; Jeong J; Sung J; Sung CO; Kim KM; Park CK; Choi MG; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S477-84. PubMed ID: 23274580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER-2/neu amplification is an independent prognostic factor in gastric cancer.
    Park DI; Yun JW; Park JH; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Yoo CH; Son BH; Cho EY; Chae SW; Kim EJ; Sohn JH; Ryu SH; Sepulveda AR
    Dig Dis Sci; 2006 Aug; 51(8):1371-9. PubMed ID: 16868827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray.
    Rakhshani N; Kalantari E; Bakhti H; Sohrabi MR; Mehrazma M
    Asian Pac J Cancer Prev; 2014; 15(18):7597-602. PubMed ID: 25292034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early HER2 dysregulation in gastric and oesophageal carcinogenesis.
    Fassan M; Mastracci L; Grillo F; Zagonel V; Bruno S; Battaglia G; Pitto F; Nitti D; Celiento T; Zaninotto G; Fiocca R; Rugge M
    Histopathology; 2012 Nov; 61(5):769-76. PubMed ID: 22882541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistent absence of HER2 expression, regardless of HER2 amplification status, in neuroendocrine carcinomas of the stomach.
    Ishida M; Sekine S; Taniguchi H; Fukagawa T; Katai H; Kushima R
    Histopathology; 2014 Jun; 64(7):1027-31. PubMed ID: 24329753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
    Park YS; Hwang HS; Park HJ; Ryu MH; Chang HM; Yook JH; Kim BS; Jang SJ; Kang YK
    Hum Pathol; 2012 Mar; 43(3):413-22. PubMed ID: 21855114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
    Berezowska S; Novotny A; Bauer K; Feuchtinger A; Slotta-Huspenina J; Becker K; Langer R; Walch A
    PLoS One; 2013; 8(7):e69098. PubMed ID: 23874879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant intratumoral heterogeneity of human epidermal growth factor receptor 2 status in gastric cancer: A comparative study of immunohistochemistry, FISH, and dual-color in situ hybridization.
    Kanayama K; Imai H; Yoneda M; Hirokawa YS; Shiraishi T
    Cancer Sci; 2016 Apr; 107(4):536-42. PubMed ID: 26752196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human epidermal growth factor receptor 2 expression in mixed gastric carcinoma.
    Wang YK; Chen Z; Yun T; Li CY; Jiang B; Lv XX; Chu GH; Wang SN; Yan H; Shi LF
    World J Gastroenterol; 2015 Apr; 21(15):4680-7. PubMed ID: 25914479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between HER2/neu gene amplification and protein expression and prognosis in patients with advanced gastric carcinoma].
    Song Y; Huang J; Wang JW
    Chin J Cancer; 2010 Jan; 29(1):76-81. PubMed ID: 20038314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral heterogeneity determines discordant results of diagnostic tests for human epidermal growth factor receptor (HER) 2 in gastric cancer specimens.
    Yang J; Luo H; Li Y; Li J; Cai Z; Su X; Dai D; Du W; Chen T; Chen M
    Cell Biochem Biophys; 2012 Jan; 62(1):221-8. PubMed ID: 21927816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK).
    Saito M; Yamashita K; Arimura Y; Kaneto H; Okuda H; Nojima M; Hagiwara T; Suzuki K; Adachi T; Goto A; Nakachi K; Yawata A; Yoshimoto M; Tanuma T; Adachi Y; Yamaoka S; Mizukoshi T; Kawayama M; Hamamoto Y; Shinomura Y
    Acta Oncol; 2016; 55(3):309-17. PubMed ID: 26757197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the protein expression and gene amplification of HER2 in gastric cancer].
    Liu JL; Li ZK; Xin FJ; Zhao H; Zhao W; Gao Y; Hu JL; Zhang XX; Zhang MS; Zhang BY; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):898-901. PubMed ID: 24062004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HER2 gene and HER2 protein status and chromosome 17 polysomy in gastric cancer cells in own material.
    Ciesielski M; Kruszewski WJ; Śmiałek U; Walczak J; Szajewski M; Szefel J; Wydra J; Kawecki K
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):113-7. PubMed ID: 25203430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of human epidermal growth factor receptor 2 status in urothelial carcinoma of the upper urinary tract: a study using dual-color in situ hybridization and immunohistochemistry.
    Vershasselt-Crinquette M; Colin P; Ouzzane A; Gnemmi V; Robin YM; Aubert S; Villers A; Leroy X
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):363-6. PubMed ID: 22495372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case.
    Saito T; Kondo C; Shitara K; Ito Y; Saito N; Ikehara Y; Yatabe Y; Yamamichi K; Tanaka H; Nakanishi H
    Pathol Int; 2015 Jun; 65(6):309-17. PubMed ID: 25828363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.